Key result
Intravenous beta-blockers with intrinsic sympathomimetic activity induced significantly less depression of left ventricular function than those without this property in coronary heart disease.
Why the study?
Do intravenous beta-blockers with intrinsic sympathomimetic activity cause less depression of left ventricular function compared to those without in patients with coronary heart disease?
Do intravenous beta-blockers with intrinsic sympathomimetic activity cause less depression of left ventricular function compared to those without in patients with coronary heart disease?
Intravenous beta-blockers with intrinsic sympathomimetic activity appear to be more effective in maintaining cardiac function than those without this property in patients with coronary heart disease.
Answers are grounded in this paper and cite their sources.
Questions clinical relevance of ancillary beta-blocker properties for LV effects in CHD; leaves open larger comparative trials.
Beta-blocking drugs are increasingly prescribed in coronary heart disease, but controversy surrounds the hemodynamic relevance of their ancillary pharmacologic properties--cardioselectivity and intrinsic sympathomimetic activity. We therefore compared the effects of four intravenous beta-adrenoreceptor antagonists with different ancillary properties on left ventricular function in 24 patients with coronary heart disease. All four drugs depressed the relation between left ventricular filling pressure and cardiac output at rest and during exercise. However, practolol and oxprenolol, which have intrinsic sympathomimetic activity, induced significantly less depression of left ventricular function than either propranolol or metoprolol, which do not have this activity. Cardioselectivity, a property of both practolol and metoprolol, had no discernible hemodynamic advantage. Beta-blocking drugs that have intrinsic sympathomimetic activity appear to be more effective in maintaining cardiac function than drugs without this property, when given intravenously to patients with coronary heart disease.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (1982) studied coronary heart disease (n=24). Intravenous beta-blockers with intrinsic sympathomimetic activity (practolol and oxprenolol) vs. Intravenous beta-blockers without intrinsic sympathomimetic activity (propranolol or metoprolol) was evaluated on depression of left ventricular function (relation between left ventricular filling pressure and cardiac output at rest and during exercise). Intravenous beta-blockers with intrinsic sympathomimetic activity induced significantly less depression of left ventricular function than those without this property in coronary heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: